{"id":"W2993442462","doi":"10.4155/bio-2019-0260","title":"2019 White Paper on Recent Issues in Bioanalysis: Chromatographic Assays (Part 1 – Innovation in Small Molecules and Oligonucleotides & Mass Spectrometric Method Development Strategies for Large Molecule Bioanalysis)","year":2019,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Caprion (Canada)","funders":"Angelini Pharma; U.S. Food and Drug Administration; Bristol-Myers Squibb; Ministry of Health, Labour and Welfare; Agence Nationale de Sécurité du Médicament et des Produits de Santé; Biogen; GlaxoSmithKline; Health Canada; AstraZeneca","keywords":"Bioanalysis; Oligonucleotide; Small molecule; Chemistry; Chromatography; Biochemical engineering; Nanotechnology; Materials science; Biochemistry; DNA; Engineering","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003437535,0.0006232061,0.001480234,0.005466844,0.0001585291,0.0001591351,0.0004329074,0.000597238,0.001065599],"category_scores_gemma":[0.0003269663,0.0005209396,0.0003857851,0.009687512,0.000139568,0.0002057406,0.0001394873,0.0004621571,0.0001046617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001742948,"about_ca_system_score_gemma":0.000134571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002816191,"about_ca_topic_score_gemma":0.002569088,"domain_scores_codex":[0.9951205,0.0008439216,0.001599007,0.001296877,0.000183863,0.000955842],"domain_scores_gemma":[0.9979498,0.000420689,0.0005147767,0.0007348695,0.0003107762,0.00006904818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001932141,0.004884314,0.3439683,0.0008684031,0.02270503,0.00005496258,0.002113619,0.001238588,0.4496663,0.06721728,0.002497684,0.1028534],"study_design_scores_gemma":[0.0133932,0.001551554,0.1495355,0.0007834249,0.005948583,0.00002855938,0.008937337,0.005183231,0.1093991,0.01104266,0.688589,0.005607868],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8001999,0.0939668,0.08121224,0.01372135,0.0008883583,0.003707027,0.0005776205,0.000393374,0.005333388],"genre_scores_gemma":[0.7823154,0.009294024,0.2001278,0.001972594,0.00007835174,0.0002737069,0.001281593,0.0001342607,0.004522292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6860913,"threshold_uncertainty_score":0.9998476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02512474401158009,"score_gpt":0.298806687511765,"score_spread":0.2736819435001849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}